PLGA-based drug delivery systems in treating bone tumors

Area of Science:

• Biomaterials Science
• Oncology
• Drug Delivery Systems

Background:

• Bone tumors pose significant health risks, with surgical removal often leading to incomplete tumor clearance and local recurrence.
• Conventional chemotherapy for bone tumors requires high doses, resulting in severe systemic toxicity and poor patient tolerance.

Purpose of the Study:

• To review the advancements in poly(lactic-co-glycolic)-acid (PLGA)-based drug delivery systems for bone tumor treatment.
• To explore the potential of PLGA nano and scaffold-based systems in improving chemotherapeutic efficacy and promoting bone regeneration.

Main Methods:

• Literature review of research on PLGA-based drug delivery systems in bone tumor applications.
• Analysis of studies focusing on PLGA nano delivery systems and PLGA scaffold-based local delivery systems.

Main Results:

• PLGA-based systems demonstrate potential for localized drug delivery, enhancing anti-tumor effects.
• These systems can aid in bone defect repair and regeneration post-tumor resection.
• PLGA nano and scaffold systems offer a promising alternative to systemic chemotherapy, potentially reducing side effects.

Conclusions:

• PLGA-based drug delivery systems represent a significant advancement in bone tumor therapy.
• Further research into these systems can lead to novel treatment strategies with improved outcomes.
• PLGA systems hold promise for effectively treating bone tumors while supporting bone healing.